What is the overall global market size of the neuro-oncology diagnostics market in 2022?

Global Neuro-Oncology Diagnostics Market was valued at USD 1.80 Billion and is projected to reach a market size of USD 3.21 Billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 8.6%.

What is the projected Global NeuroOncology Diagnostics Market growth rate under the study period?

The worldwide global neuro-oncology diagnostics market growth is estimated to grow by around 8.6% from 2023 to 2030.

What is the Global NeuroOncology Diagnostics Market segmentation covered in the report?

The Global NeuroOncology Diagnostics Market is segmented by Test Type, by Cancer Type, by Age Group, and by End User.

What are the potential future trends and opportunities for the Global Neuro-Oncology Diagnostics Market?

The market is expected to see growth through rising awareness of early diagnosis of brain cancer, advancements in technologies like improved imaging techniques, along innovation in drug delivery to brain cancer increasing the size of the market.

What impact has the COVID-19 pandemic had on the Global Neuro-Oncology market?

The COVID-19 pandemic disrupted the supply chain of the diagnostic market reducing the overall market size in 2020. However, the market is increasing as people have to get diagnosed after the lockdown scenario.